From Wikipedia, the free encyclopedia
Jump to: navigation, search
JSC Pharmstandard
Public (OAO)
Industry Pharmaceuticals
Founded 2003
Headquarters Dolgoprudny, Russia
Key people
Viktor Vladimirovich Kharitonin,(Chairman)
Igor Konstantinovich Krylov, (CEO)
Products Remedies
Revenue Increase US$ 1.6 billion (2012)
Profit Increase US$ 321.1 million (2012)
Number of employees

Pharmstandard is the leading Russian pharmaceutical company, it is headquartered in Dolgoprudny.

Pharmstandard portfolio includes over 200 products used in the treatment of diabetes, growth hormone deficiency, cardiovascular diseases, gastroenterological and neurological disorders, infectious diseases, cancer, etc. Over 90 products offered by Pharmstandard are included in the List of Vital Pharmaceutical Products.[1]

The company has six manufacturing facilities located in Moscow, Ufa, Nizhny Novgorod, Kursk, Tomsk and Tyumen.

Pharmstandard was delisted from the London and Moscow stock exchanges in 2017.[2]